These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7128472)

  • 1. [Myelosuppression with macrocytic anaemia and leucopenia during treatment with azathioprine in myasthenia gravis].
    Reinicke H; Weber FW; Hausamen TU
    Dtsch Med Wochenschr; 1982 Oct; 107(42):1592-4. PubMed ID: 7128472
    [No Abstract]   [Full Text] [Related]  

  • 2. [Correlation of clinical and morphological parameters in chronic hepatitis during long-term treatment with azathioprine].
    Platzer S; Asamer H; Födisch HJ; Gabl F; Huber H; Judmaier G; Spath P
    Wien Klin Wochenschr; 1973 Jul; 85(29):509-14. PubMed ID: 4723700
    [No Abstract]   [Full Text] [Related]  

  • 3. A Review of Azathioprine-Associated Hepatotoxicity and Myelosuppression in Myasthenia Gravis.
    Jack KL; Koopman WJ; Hulley D; Nicolle MW
    J Clin Neuromuscul Dis; 2016 Sep; 18(1):12-20. PubMed ID: 27552384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azathioprine in the treatment of myasthenia gravis.
    Witte AS; Cornblath DR; Parry GJ; Lisak RP; Schatz NJ
    Ann Neurol; 1984 Jun; 15(6):602-5. PubMed ID: 6742794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azathioprine experience in severe, generalized, recalcitrant myasthenia gravis.
    Kornfeld P; Ambinder EP; Matta R; Bender A; Papatestas AE; Gross H; Genkins G
    Mt Sinai J Med; 1985 May; 52(5):347-52. PubMed ID: 3874354
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pancytopenia following combination treatment with allopurinol and azathioprine].
    Glogner P; Heni N
    Med Welt; 1976 Aug; 27(33):1545-6. PubMed ID: 957985
    [No Abstract]   [Full Text] [Related]  

  • 7. Azathioprine as a single immunosuppressive drug in the treatment of myasthenia gravis.
    Cosi V; Lombardi M; Erbetta A; Piccolo G
    Acta Neurol (Napoli); 1993 Apr; 15(2):123-31. PubMed ID: 8328322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of primary central nervous system lymphoma with long-term azathioprine therapy for myasthenia gravis?
    Herrlinger U; Weller M; Dichgans J; Melms A
    Ann Neurol; 2000 May; 47(5):682-3. PubMed ID: 10805346
    [No Abstract]   [Full Text] [Related]  

  • 9. Allopurinol-azathioprine interaction.
    Boyd IW
    J Intern Med; 1991 Apr; 229(4):386. PubMed ID: 2026995
    [No Abstract]   [Full Text] [Related]  

  • 10. [Megaloblastic anemia following treatment of rheumatoid arthritis with azathioprine].
    Christoph R; Pirnay D; Hartl W
    Med Welt; 1971 Nov; 46():1824-7. PubMed ID: 5131885
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hypersensitivity to azathioprine can simulate an aggravation of myasthenia].
    Chevrel G; Moreau T; Vial T; Payen C; Confavreux C
    Therapie; 1998; 53(1):77-8. PubMed ID: 9773103
    [No Abstract]   [Full Text] [Related]  

  • 12. Portal hypertension secondary to azathioprine in myasthenia gravis.
    Fonseca V; Havard CW
    Postgrad Med J; 1988 Dec; 64(758):950-2. PubMed ID: 3256814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of megaloblastic anemia induced by azathioprine (author's transl)].
    Taguchi H; Yoshimoto S; Machida K; Yorimitsu Y; Niiya K; Shiomi F; Ueda N
    Rinsho Ketsueki; 1980 May; 21(5):660-4. PubMed ID: 7191017
    [No Abstract]   [Full Text] [Related]  

  • 14. Azathioprine-induced reversible severe dyserythropoiesis as a cause of anemia.
    Raman SB; Abraham JP; Saeed SM; Sawdyk M
    Henry Ford Hosp Med J; 1986; 34(3):202-6. PubMed ID: 3804776
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypersensitivity to azathioprine in myasthenia gravis.
    Watts GF; Corston R
    Postgrad Med J; 1984 May; 60(703):362-3. PubMed ID: 6539914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive drugs: azathioprine in the treatment of myasthenia gravis.
    Matell G
    Ann N Y Acad Sci; 1987; 505():589-94. PubMed ID: 3479940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of malignancy in myasthenia gravis patients exposed to azathioprine therapy for a median period of 3 years.
    Rawoot A; Little F; Heckmann JM
    S Afr Med J; 2006 Dec; 96(12):1249-51. PubMed ID: 17252153
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe megaloblastic anaemia associated with abnormal azathioprine metabolism.
    Lennard L; Murphy MF; Maddocks JL
    Br J Clin Pharmacol; 1984 Feb; 17(2):171-2. PubMed ID: 6704287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report. Azathioprine-induced megaloblastic erythropoiesis.
    Torres L; Trubowitz S; Davis S
    J Med Soc N J; 1978 Apr; 75(4):323-5. PubMed ID: 273109
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased danger of bone marrow damage in simultaneous azathioprine-allopurinol therapy.
    Zazgornik J; Kopsa H; Schmidt P; Pils P; Kuschan K; Deutsch E
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):96-7. PubMed ID: 7228457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.